4-isobutyl-3,8a-dihydroimidazo[4,5-c]azepin-2-amine

ID: ALA604872

PubChem CID: 46224848

Max Phase: Preclinical

Molecular Formula: C11H16N4

Molecular Weight: 204.28

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)CC1=C2NC(N)=NC2C=CC=N1

Standard InChI:  InChI=1S/C11H16N4/c1-7(2)6-9-10-8(4-3-5-13-9)14-11(12)15-10/h3-5,7-8H,6H2,1-2H3,(H3,12,14,15)

Standard InChI Key:  HWNUMHPIOXMCTP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
    3.8939  -18.8603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4099  -19.5342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9012  -20.2026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5849  -19.5388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0977  -20.2368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4235  -19.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0462  -18.7975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3182  -20.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6914  -19.9428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6841  -19.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2791  -18.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3130  -21.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0249  -21.6752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0197  -22.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7420  -21.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
 10  1  1  0
  5  6  2  0
  6  7  1  0
  5  8  1  0
  9 10  1  0
 10 11  1  0
 11  7  2  0
  8  9  2  0
  1  2  2  0
  8 12  1  0
  2  3  1  0
 12 13  1  0
  3  9  1  0
 13 14  1  0
 13 15  1  0
M  END

Associated Targets(Human)

U-266 (527 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2058 (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 204.28Molecular Weight (Monoisotopic): 204.1375AlogP: 1.17#Rotatable Bonds: 2
Polar Surface Area: 62.77Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.49CX LogP: 0.33CX LogD: -1.63
Aromatic Rings: Heavy Atoms: 15QED Weighted: 0.71Np Likeness Score: 0.38

References

1. Ma Y, Nam S, Jove R, Yakushijin K, Horne DA..  (2010)  Synthesis and anticancer activities of ageladine A and structural analogs.,  20  (1): [PMID:19948404] [10.1016/j.bmcl.2009.11.036]

Source